Multivalent Vaccines

Global Multivalent Vaccines Market Data Survey Report 2013-2025

Report ID: HeyReport 20426 | Number of pages: 63 | Publish Date: Apr 2019 | Category: Lifesciences and Healthcare
Summary
The global Multivalent Vaccines market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    GlaxoSmithKline, plc (U.K.)
    Pfizer, Inc. (U.S.)
    Merck & Co., Inc. (U.S.)
    Sanofi Pasteur SA (France)
    Astellas Pharma Inc. (Japan)
    CSL Limited (Australia)
    Emergent BioSolutions, Inc. (U.S.)
    Johnson & Johnson (U.S.)
    MedImmune, LLC (U.S.)
    Serum Institute of India Pvt. Ltd. (India)
    Bavarian Nordic (Denmark)
    Mitsubishi Tanabe Pharma Corporation (Japan)
    Daiichi Sankyo (Japan)
    Protein Sciences Corporation (U.S.)
    Panacea Biotec (India)
Major applications as follows:
    Pediatrics
    Adults
Major Type as follows:
    Conjugate Vaccines
    Inactivated and Subunit Vaccines
    Live Attenuated Vaccines
    Toxoid Vaccines
    Recombinant Vaccines
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 GlaxoSmithKline, plc (U.K.)
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 Pfizer, Inc. (U.S.)
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Merck & Co., Inc. (U.S.)
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 Sanofi Pasteur SA (France)
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 Astellas Pharma Inc. (Japan)
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 CSL Limited (Australia)
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 Emergent BioSolutions, Inc. (U.S.)
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 Johnson & Johnson (U.S.)
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.8.4 Recent Development
    3.9 MedImmune, LLC (U.S.)
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.9.4 Recent Development
    3.10 Serum Institute of India Pvt. Ltd. (India)
        3.10.1 Company Information
        3.10.2 Product & Services
        3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.10.4 Recent Development
    3.11 Bavarian Nordic (Denmark)
        3.11.1 Company Information
        3.11.2 Product & Services
        3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.11.4 Recent Development
    3.12 Mitsubishi Tanabe Pharma Corporation (Japan)
        3.12.1 Company Information
        3.12.2 Product & Services
        3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.12.4 Recent Development
    3.13 Daiichi Sankyo (Japan)
        3.13.1 Company Information
        3.13.2 Product & Services
        3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.13.4 Recent Development
    3.14 Protein Sciences Corporation (U.S.)
        3.14.1 Company Information
        3.14.2 Product & Services
        3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.15 Panacea Biotec (India)
        3.15.1 Company Information
        3.15.2 Product & Services
        3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Pediatrics
        4.1.1 Overview
        4.1.2 Pediatrics Market Size and Forecast
    4.2 Adults
        4.2.1 Overview
        4.2.2 Adults Market Size and Forecast
5 Market by Type
    5.By Conjugate Vaccines
    5.1 Conjugate Vaccines
        5.1.1 Overview
        5.1.2 Conjugate Vaccines Market Size and Forecast
    5.2 Inactivated and Subunit Vaccines
        5.2.1 Overview
        5.2.2 Inactivated and Subunit Vaccines Market Size and Forecast
    5.3 Live Attenuated Vaccines
        5.3.1 Overview
        5.3.2 Live Attenuated Vaccines Market Size and Forecast
    5.4 Toxoid Vaccines
        5.4.1 Overview
        5.4.2 Toxoid Vaccines Market Size and Forecast
    5.5 Recombinant Vaccines
        5.5.1 Overview
        5.5.2 Recombinant Vaccines Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline, plc (U.K.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer, Inc. (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck & Co., Inc. (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi Pasteur SA (France)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas Pharma Inc. (Japan)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CSL Limited (Australia)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Emergent BioSolutions, Inc. (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Johnson & Johnson (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of MedImmune, LLC (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Serum Institute of India Pvt. Ltd. (India)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bavarian Nordic (Denmark)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma Corporation (Japan)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Daiichi Sankyo (Japan)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Protein Sciences Corporation (U.S.)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Panacea Biotec (India)
Fig Global Multivalent Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Global Multivalent Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Global Multivalent Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Multivalent Vaccines Market Forecast and CAGR 2019-2025 (Volume)
Fig Pediatrics Market Size and CAGR 2013-2018 (Million USD)
Fig Pediatrics Market Size and CAGR 2013-2018 (Volume)
Fig Pediatrics Market Forecast and CAGR 2019-2025 (Million USD)
Fig Pediatrics Market Forecast and CAGR 2019-2025 (Volume)
Fig Adults Market Size and CAGR 2013-2018 (Million USD)
Fig Adults Market Size and CAGR 2013-2018 (Volume)
Fig Adults Market Forecast and CAGR 2019-2025 (Million USD)
Fig Adults Market Forecast and CAGR 2019-2025 (Volume)
Fig Conjugate Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Conjugate Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Conjugate Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Conjugate Vaccines Market Forecast and CAGR 2019-2025 (Volume)
Fig Inactivated and Subunit Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Inactivated and Subunit Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Inactivated and Subunit Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Inactivated and Subunit Vaccines Market Forecast and CAGR 2019-2025 (Volume)
Fig Live Attenuated Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Live Attenuated Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Live Attenuated Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Live Attenuated Vaccines Market Forecast and CAGR 2019-2025 (Volume)
Fig Toxoid Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Toxoid Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Toxoid Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Toxoid Vaccines Market Forecast and CAGR 2019-2025 (Volume)
Fig Recombinant Vaccines Market Size and CAGR 2013-2018 (Million USD)
Fig Recombinant Vaccines Market Size and CAGR 2013-2018 (Volume)
Fig Recombinant Vaccines Market Forecast and CAGR 2019-2025 (Million USD)
Fig Recombinant Vaccines Market Forecast and CAGR 2019-2025 (Volume)